ICICI Securities has maintained a BUY rating on Shriram Finance (SHRTRA) with a target price of Rs 1,200, implying an upside of ~19% from the current market price of Rs 1,011.
News in Focus


Since October 1, 2025, a nationwide ban on real-money online gaming has been in effect in India.

Sunteck Realty has delivered a robust operational and financial performance in FY26, reinforcing its positioning as a premium real estate developer in the Mumbai Metropolitan Region.

ICICI Securities has upgraded Cipla to a BUY rating with a revised target price of Rs 1,550, implying a potential upside of nearly 19% from the current market price of Rs 1,306.

ICICI Securities has reiterated its BUY call on Tata Communications, setting a revised target price of Rs 2,100, implying an upside potential of nearly 38% from the current market price of Rs 1,525

Infosys, backed by a BUY recommendation from Deven Choksey Research, is entering a decisive phase where artificial intelligence moves from experimentation to real-world monetization.
Main Regional Stories

China’s DeepSeek has re-entered the spotlight with the unveiling of its latest artificial intelligence models, marking a pivotal moment in the evolving global competition for AI dominance.

IDBI Capital has reiterated a BUY rating on Tech Mahindra (TECHM) with a revised target price of Rs 1,697, implying a potential upside of ~16% from the current market price of Rs 1,463.

Safety is a major concern for every Indian biker. Riders suffer from traffic jams, potholes, and other hassles during their daily travel. A minor accident or bike damage can disrupt your routine and affect your budget.

Prabhudas Lilladher (PL Capital) has upgraded SBI Life Insurance to a BUY rating with a target price of Rs 2,200, implying meaningful upside from the current market price of Rs 1,885.

Research has suggested that the detection of cervical cancer is more accurate using a blood test compared to Pap smears (Papanicolaou test). The study has suggested that HPV (Human Papilloma Virus) is found in 95% of cases of development of cervical cancer in cervix. The study published in the New England Journal of Medicine has suggested that individuals should directly go for HPV test instead of Pap smears.








